Bo G Danielson, professor at Akademiska Sjukhuset Uppsala and specialist in internal medicin founded Renapharma year 2000 after 30 years of dedication to Health Care and special emphasis on Kidney Disease.
Within the frames of Renpharma his scientific contribution continued with extensive clinical trial programs aimed to measure effects of Iron supplementation.
Today Renapharma continues this heritage and has a genuine strive for high scientific standards in all therapeutic area.
To support patients and health care institutions by combining the scientific dialogue with innovative technology by providing products within pharmaceuticals, Nutraceuticals and Medtech industries.
To improve quality of life of patients and facilitate for daily health care institutions with new innovative Pharmaceuticals, Nutraceuticals and Medtech
To excel in the capabilities required for serving, launching and establishing new trademarks within the healthcare sector as well as optimising the market potential. And to be an attractive partner for launching new products and ideas on the markets Renapharma is present on.